Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma
about
Cardioprotective effects of PKG activation by soluble GC activator, BAY 60-2770, in ischemia-reperfusion-injured rat hearts.A Three-Dimensional Chondrocyte-Macrophage Coculture System to Probe Inflammation in Experimental Osteoarthritis.Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling.Hsp90 chaperones hemoglobin maturation in erythroid and nonerythroid cells.A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection.Comparative Studies of the Dynamics Effects of BAY60-2770 and BAY58-2667 Binding with Human and Bacterial H-NOX Domains
P2860
Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma
@en
type
label
Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma
@en
prefLabel
Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma
@en
P2093
P2860
P356
P1476
Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma
@en
P2093
Andreas Friebe
Arnab Ghosh
Cynthia J Koziol-White
Dennis J Stuehr
Dieter Groneberg
Georgina Cheng
Kewal Asosingh
Lisa Ruple
Mark A Aronica
Reynold A Panettieri
P2860
P304
P356
10.1073/PNAS.1524398113
P407
P577
2016-04-11T00:00:00Z